Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrase MT20 in children with CF and pancreatic insufficiency
NCT00513682Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Jul 2007
- Primary completion
- Mar 2008
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of pancrelipase in exocrine pancreatic insufficiency (EPI), sponsored by Forest Laboratories. Started Jul 2007; status: completed.
02
Drugs
pancrelipase
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT00513682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00513682.